Chesley Taft & Associates Has Decreased General Electric (GE) Holding By $1.54 Million; Cyanotech (CYAN) Sentiment Is 1

General Electric Company (NYSE:GE) Logo

Chesley Taft & Associates Llc decreased General Electric Corporation (GE) stake by 18.23% reported in 2017Q4 SEC filing. Chesley Taft & Associates Llc sold 90,310 shares as General Electric Corporation (GE)’s stock declined 23.20%. The Chesley Taft & Associates Llc holds 405,102 shares with $7.07 million value, down from 495,412 last quarter. General Electric Corporation now has $126.20B valuation. The stock increased 1.82% or $0.2599 during the last trading session, reaching $14.5299. About 13.75M shares traded. General Electric Company (NYSE:GE) has declined 54.35% since May 9, 2017 and is downtrending. It has underperformed by 65.90% the S&P500.

Cyanotech Corp (CYAN) investors sentiment decreased to 1 in Q4 2017. It’s down -0.67, from 1.67 in 2017Q3. The ratio dropped, as 4 investment professionals increased or opened new stock positions, while 4 decreased and sold their stakes in Cyanotech Corp. The investment professionals in our database now hold: 930,630 shares, up from 911,964 shares in 2017Q3. Also, the number of investment professionals holding Cyanotech Corp in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 2 Increased: 3 New Position: 1.

Since January 26, 2018, it had 1 insider purchase, and 0 sales for $43,446 activity. DIMITRIEF ALEXANDER also bought $43,446 worth of General Electric Company (NYSE:GE) shares.

Chesley Taft & Associates Llc increased Walgreens Boots Alliance Inc. stake by 85,423 shares to 261,369 valued at $18.98M in 2017Q4. It also upped Paypal Holdings Inc. stake by 17,350 shares and now owns 24,350 shares. S&P Global Inc. was raised too.

More notable recent General Electric Company (NYSE:GE) news were published by: which released: “General Electric Company (NYSE:GE) Is GE a Buy?” on May 09, 2018, also with their article: “Should You Buy General Electric Company Stock? 3 Pros, 3 Cons” published on May 07, 2018, published: “GE’s stock surges to pace Dow gainers” on May 08, 2018. More interesting news about General Electric Company (NYSE:GE) were released by: and their article: “General Electric’s Death Could Be Best For Shareholders” published on April 25, 2018 as well as‘s news article titled: “3D printing for the military at GE” with publication date: May 02, 2018.

Investors sentiment decreased to 0.5 in Q4 2017. Its down 0.19, from 0.69 in 2017Q3. It is negative, as 153 investors sold GE shares while 921 reduced holdings. 151 funds opened positions while 383 raised stakes. 4.69 billion shares or 0.29% less from 4.70 billion shares in 2017Q3 were reported. Oppenheimer Asset Mngmt owns 493,139 shares. Ntv Asset Management Ltd Co reported 177,727 shares. Crestwood Advsrs Lc invested in 46,675 shares or 0.06% of the stock. Westwood invested 0% in General Electric Company (NYSE:GE). Markston Int Ltd Liability Com holds 15,685 shares or 0.03% of its portfolio. 3.54M were reported by Hermes Investment Mgmt Ltd. Pecaut reported 1.57% of its portfolio in General Electric Company (NYSE:GE). London Co Of Virginia holds 7.79 million shares or 0.99% of its portfolio. Rockland Trust reported 223,265 shares. 323,077 are held by Trustco Bankshares N Y. Grp One Trading Ltd Partnership owns 2.24M shares. Moreover, Alyeska Inv Grp LP has 1.28% invested in General Electric Company (NYSE:GE) for 8.55 million shares. Jones Financial Lllp reported 0.01% in General Electric Company (NYSE:GE). Glg Ptnrs LP has invested 0% in General Electric Company (NYSE:GE). Prudential Plc has 4.80M shares.

Among 28 analysts covering General Electric Company (NYSE:GE), 8 have Buy rating, 6 Sell and 14 Hold. Therefore 29% are positive. General Electric Company has $67 highest and $1100 lowest target. $24.91’s average target is 71.44% above currents $14.5299 stock price. General Electric Company had 101 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, August 25 the stock rating was maintained by Deutsche Bank with “Hold”. The company was maintained on Tuesday, November 21 by Deutsche Bank. The stock has “Buy” rating by Bank of America on Tuesday, November 14. The company was upgraded on Monday, November 13 by Langenberg. The rating was downgraded by Oppenheimer on Monday, September 21 to “Perform”. The firm earned “Underweight” rating on Monday, February 12 by JP Morgan. The company was maintained on Wednesday, October 14 by S&P Research. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, January 25 report. The rating was maintained by RBC Capital Markets with “Positive” on Thursday, March 23. The firm earned “Sell” rating on Friday, May 12 by Deutsche Bank.

Coastline Trust Co holds 0.05% of its portfolio in Cyanotech Corporation for 82,400 shares. Finemark National Bank & Trust owns 102,826 shares or 0.03% of their US portfolio. Moreover, Blackrock Inc. has 0% invested in the company for 11,574 shares. The California-based California Public Employees Retirement System has invested 0% in the stock. Deutsche Bank Ag, a Germany-based fund reported 104 shares.

The stock decreased 0.48% or $0.02 during the last trading session, reaching $4.1. About 700 shares traded. Cyanotech Corporation (CYAN) has risen 20.48% since May 9, 2017 and is uptrending. It has outperformed by 8.93% the S&P500.

More recent Cyanotech Corporation (NASDAQ:CYAN) news were published by: which released: “Cyanotech: An Opportune Moment To Buy” on April 18, 2018. Also published the news titled: “Acacia Communications Stock Heads Toward Worst Day Ever on ZTE Ban” on April 16, 2018.‘s news article titled: “31 Stocks Moving In Monday’s Mid-Day Session” with publication date: April 16, 2018 was also an interesting one.

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition market worldwide. The company has market cap of $23.59 million. The companyÂ’s products include Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids; and Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the bodyÂ’s natural inflammatory response, enhance skin, and support eye and joint health. It has a 12.93 P/E ratio. Cyanotech Corporation sells its products in bulk quantities to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets; and as packaged consumer products to distributors, retailers, and direct consumers.

General Electric Company (NYSE:GE) Institutional Positions Chart